221 related articles for article (PubMed ID: 24013355)
1. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.
Douradinha B; Reis VC; Rogers MB; Torres FA; Evans JD; Marques ET
Bioengineered; 2014; 5(1):21-9. PubMed ID: 24013355
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome-wide differences between Saccharomyces cerevisiae and Saccharomyces cerevisiae var. boulardii: Clues on host survival and probiotic activity based on promoter sequence variability.
Pais P; Oliveira J; Almeida V; Yilmaz M; Monteiro PT; Teixeira MC
Genomics; 2021 Mar; 113(2):530-539. PubMed ID: 33482324
[TBL] [Abstract][Full Text] [Related]
3. A Mutation in
Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
[TBL] [Abstract][Full Text] [Related]
4. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
[TBL] [Abstract][Full Text] [Related]
5. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
Sen S; Mansell TJ
Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
[TBL] [Abstract][Full Text] [Related]
6. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
[TBL] [Abstract][Full Text] [Related]
7. New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Samakkarn W; Vandecruys P; Moreno MRF; Thevelein J; Ratanakhanokchai K; Soontorngun N
Appl Microbiol Biotechnol; 2024 Jan; 108(1):153. PubMed ID: 38240846
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Datta S; Timson DJ; Annapure US
J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Engineering of Probiotic Saccharomyces boulardii.
Liu JJ; Kong II; Zhang GC; Jayakody LN; Kim H; Xia PF; Kwak S; Sung BH; Sohn JH; Walukiewicz HE; Rao CV; Jin YS
Appl Environ Microbiol; 2016 Apr; 82(8):2280-2287. PubMed ID: 26850302
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis for probiotic yeast phenotypes revealed by nanopore sequencing.
Collins JH; Kunyeit L; Weintraub S; Sharma N; White C; Haq N; Anu-Appaiah KA; Rao RP; Young EM
G3 (Bethesda); 2023 Aug; 13(8):. PubMed ID: 37103477
[TBL] [Abstract][Full Text] [Related]
11. The establishment of Saccharomyces boulardii surface display system using a single expression vector.
Wang T; Sun H; Zhang J; Liu Q; Wang L; Chen P; Wang F; Li H; Xiao Y; Zhao X
Fungal Genet Biol; 2014 Mar; 64():1-10. PubMed ID: 24309301
[TBL] [Abstract][Full Text] [Related]
12. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
[TBL] [Abstract][Full Text] [Related]
13. [Construction and preliminary applications of a Saccharomyces cerevisiae detection plasmid using for screening promoter elements].
Wang ZF; Wang ZB; Li LN; Jian-Mei AN; Wang-Wei ; Cheng KD; Kong JQ
Yao Xue Xue Bao; 2013 Feb; 48(2):228-35. PubMed ID: 23672019
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae.
Edwards-Ingram L; Gitsham P; Burton N; Warhurst G; Clarke I; Hoyle D; Oliver SG; Stateva L
Appl Environ Microbiol; 2007 Apr; 73(8):2458-67. PubMed ID: 17293506
[TBL] [Abstract][Full Text] [Related]
15. A Tunable and Expandable Transactivation System in Probiotic Yeast
Kwak S; Mahmud B; Dantas G
ACS Synth Biol; 2022 Jan; 11(1):508-514. PubMed ID: 34939781
[TBL] [Abstract][Full Text] [Related]
16. Microbiome Engineering Using Probiotic Yeast:
Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
[TBL] [Abstract][Full Text] [Related]
17.
Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
[No Abstract] [Full Text] [Related]
18. Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.
Fu J; Liu J; Wen X; Zhang G; Cai J; Qiao Z; An Z; Zheng J; Li L
Probiotics Antimicrob Proteins; 2023 Aug; 15(4):967-982. PubMed ID: 35608794
[TBL] [Abstract][Full Text] [Related]
19. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
[TBL] [Abstract][Full Text] [Related]
20. Enhancing probiotic impact: engineering
de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
Appl Environ Microbiol; 2024 Jun; 90(6):e0032524. PubMed ID: 38752748
[No Abstract] [Full Text] [Related]
[Next] [New Search]